- Home
- ONEW vs ZURA Comparison
ONEW vs ZURA Comparison
Compare ONEW & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEW
- ZURA
- Stock Information
- Founded
- ONEW 2014
- ZURA 2022
- Country
- ONEW United States
- ZURA United States
- Employees
- ONEW N/A
- ZURA N/A
- Industry
- ONEW Auto & Home Supply Stores
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONEW Consumer Discretionary
- ZURA Health Care
- Exchange
- ONEW Nasdaq
- ZURA Nasdaq
- Market Cap
- ONEW 244.4M
- ZURA 69.9M
- IPO Year
- ONEW 2020
- ZURA N/A
- Fundamental
- Price
- ONEW $15.00
- ZURA $1.13
- Analyst Decision
- ONEW Buy
- ZURA Buy
- Analyst Count
- ONEW 7
- ZURA 7
- Target Price
- ONEW $19.83
- ZURA $14.33
- AVG Volume (30 Days)
- ONEW 153.7K
- ZURA 709.5K
- Earning Date
- ONEW 07-29-2025
- ZURA 08-08-2025
- Dividend Yield
- ONEW N/A
- ZURA N/A
- EPS Growth
- ONEW N/A
- ZURA N/A
- EPS
- ONEW N/A
- ZURA N/A
- Revenue
- ONEW $1,779,631,000.00
- ZURA N/A
- Revenue This Year
- ONEW $1.60
- ZURA N/A
- Revenue Next Year
- ONEW $3.33
- ZURA N/A
- P/E Ratio
- ONEW N/A
- ZURA N/A
- Revenue Growth
- ONEW N/A
- ZURA N/A
- 52 Week Low
- ONEW $11.58
- ZURA $0.97
- 52 Week High
- ONEW $31.00
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- ONEW 57.57
- ZURA 48.73
- Support Level
- ONEW $13.11
- ZURA $1.00
- Resistance Level
- ONEW $14.08
- ZURA $1.22
- Average True Range (ATR)
- ONEW 0.79
- ZURA 0.08
- MACD
- ONEW 0.08
- ZURA -0.00
- Stochastic Oscillator
- ONEW 98.67
- ZURA 52.00
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.